MIXTURE OF HMOS AND B. INFANTIS

The invention provides a composition for use in preventing and/or treating a viral infection in a subject, wherein the composition comprises Bifidobacterium longum subsp. infantis and a HMO mixture consisting of 2'-fucosyllactose (2FL), difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-si...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	JAMES, Kieran, NOTI, Mario, DE BRUYN, Florac, FORBES-BLOM, Elizabeth, TYTGAT, Hanne Lore Paula, MAES, Dominick
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	FOODS OR FOODSTUFFS FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention provides a composition for use in preventing and/or treating a viral infection in a subject, wherein the composition comprises Bifidobacterium longum subsp. infantis and a HMO mixture consisting of 2'-fucosyllactose (2FL), difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), 3'-sialyllactose (3SL), and lacto-N-neotetraose (LNnT), and optionally 3-fucosyllactose (3FL). The invention also provides the composition for use in preventing and/or reducing the risk of allergen sensitisation, preventing and/or reducing the risk of developing a respiratory condition in a subject, and/or preventing and/or reducing the risk of developing asthma in a subject. L'invention concerne une composition destinée à être utilisée dans la prévention et/ou le traitement d'une infection virale chez un sujet, la composition comprenant Bifidobacterium longum subsp. infantis et un mélange de HMO constitué de 2'-fucosyllactose (2FL), de difucosyllactose (DFL), de lacto-N-tétraose (LNT), de 6'-sialyllactose (6SL), de 3'-sialyllactose (3SL), et de lacto-N-néotétraose (LNnT), et éventuellement de 3-fucosyllactose (3FL). L'invention concerne également la composition destinée à être utilisée dans la prévention et/ou la réduction du risque de sensibilisation aux allergènes, la prévention et/ou la réduction du risque de développer une affection respiratoire chez un sujet, et/ou la prévention et/ou la réduction du risque de développer l'asthme chez un sujet.